ETR vs SPRO · P/E 28, rev $12.95B vs P/E 9.6, rev $48.0M
Entergy Corporation (ETR) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the ETR and SPRO stock pages for the full models.
Not investment advice.